Effect of the Wnt-Signaling Inhibitor Sclerostin and Bone Marrow Adipocytes on Multiple Myeloma

被引：1
|
作者：
Panaroni, Cristina [1 ]
Siu, Ka Tat [1 ]
Fulzele, Keertik S. [2 ]
Ramachandran, Janani [1 ]
Raje, Noopur [3 ]
机构：
[1] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[2] Boston Univ, Sch Dent Med, Dept Mol & Cell Biol, Boston, MA USA
[3] Massachusetts Gen Hosp, Canc Ctr, Ctr Multiple Myeloma, Boston, MA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2077.2077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2077
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Wnt signaling pathway inhibitor, sclerostin, correlates with bone pain and bone marrow infiltration in patients with Gaucher disease
    Dao, Julia
    Noll, Lauren
    Friedman, Andrew
    Goker-Alpan, Ozlem
    Ivanova, Margarita
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S35 - S35
  • [2] Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
    M. Chiarito
    L. Piacente
    N. Chaoul
    P. Pontrelli
    G. D’Amato
    A. Grandone
    G. Russo
    M. E. Street
    M. G. Wasniewska
    G. Brunetti
    M. F. Faienza
    Journal of Endocrinological Investigation, 2022, 45 : 1255 - 1263
  • [3] Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
    Chiarito, M.
    Piacente, L.
    Chaoul, N.
    Pontrelli, P.
    D'Amato, G.
    Grandone, A.
    Russo, G.
    Street, M. E.
    Wasniewska, M. G.
    Brunetti, G.
    Faienza, M. F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (06) : 1255 - 1263
  • [4] In vivo WNT-signaling antagonist sFRP3 expression in multiple myeloma: Another potential pathway in myeloma bone disease.
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 258 - 258
  • [5] A DIFFERENT BALANCE IN WNT-SIGNALING IN ADULT AND FETAL BONE MARROW-DERIVED MSC
    Voermans, Carlijn
    Paciejewska, Maja
    Maijenburg, Marijke
    Gilissen, Christian
    Vermeul, Kim
    Kleijer, Marion
    Weijer, Kees
    Veltman, Joris
    von Lindern, Marieke
    van der Schoot, C.
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S75 - S75
  • [6] A DIFFERENT BALANCE IN WNT-SIGNALING IN ADULT AND FETAL BONE MARROW-DERIVED MSC
    Voermans, C.
    Paciejewska, M.
    Maijenburg, M.
    Gilissen, C.
    Vermeul, K.
    Kleijer, M.
    Weijer, K.
    Veltman, J. A.
    von Lindern, M.
    van der Schoot, C. E.
    VOX SANGUINIS, 2013, 105 : 14 - 14
  • [7] Control of Bone Homeostasis by the Wnt Inhibitor Sclerostin
    Meghan E. McGee-Lawrence
    Mark W. Hamrick
    Current Molecular Biology Reports, 2016, 2 (3) : 141 - 148
  • [8] The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
    Tian, E
    Zhan, FH
    Walker, R
    Rasmussen, E
    Ma, YP
    Barlogie, B
    Shaughnessy, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26): : 2483 - 2494
  • [9] Studies on the cellular interactions between bone marrow adipocytes and multiple myeloma cells - Do adipocytes support multiple myeloma development?
    Deleu, S.
    Caers, J.
    Belaid, Z.
    Van Riet, I.
    Defresne, M.
    De Raeve, H.
    Van Camp, B.
    Vanderkerken, K.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 105 - 105
  • [10] Bone Marrow Adipocytes Induce Metabolic Reprogramming of Multiple Myeloma Cells
    Panaroni, Cristina
    Fulzele, Keertik
    Mori, Tomoaki
    Nakamoto-Matsubara, Rie
    Maebius, Allison
    Raje, Noopur S.
    BLOOD, 2021, 138
12345